TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish Pharma Compliance AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
363
|
535
|
588 |
Financial expenses |
1
|
0
|
1 |
Earnings before taxes |
86
|
338
|
356 |
EBITDA |
85
|
338
|
356 |
Total assets |
1,259
|
1,298
|
1,275 |
Current assets |
561
|
764
|
693 |
Current liabilities |
87
|
68
|
90 |
Equity capital |
1,173
|
1,230
|
1,184 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.2%
|
94.8%
|
92.9% |
Turnover per employee |
363
|
535
|
588 |
Profit as a percentage of turnover |
23.7%
|
63.2%
|
60.5% |
Return on assets (ROA) |
6.9%
|
26.0%
|
28.0% |
Current ratio |
644.8%
|
1123.5%
|
770.0% |
Return on equity (ROE) |
7.3%
|
27.5%
|
30.1% |
Change turnover |
-175
|
-6
|
-119 |
Change turnover % |
-33%
|
-1%
|
-17% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.